NRC Files 8-K: Material Definitive Agreement Announced
Ticker: NRC · Form: 8-K · Filed: Aug 6, 2024 · CIK: 70487
| Field | Detail |
|---|---|
| Company | National Research CORP (NRC) |
| Form Type | 8-K |
| Filed Date | Aug 6, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $25 million, $27.5 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-reporting
TL;DR
NRC filed an 8-K for a material definitive agreement - details TBD.
AI Summary
National Research Corporation (NRC) announced on August 5, 2024, that it entered into a Material Definitive Agreement. The filing also covers Results of Operations and Financial Condition, along with Financial Statements and Exhibits. Specific details regarding the agreement, financial results, or exhibits were not provided in the excerpt.
Why It Matters
This filing indicates a significant business event for National Research Corporation, potentially impacting its operations and financial standing.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement, which could have significant implications, but the lack of specific details prevents a definitive risk assessment.
Key Players & Entities
- National Research Corporation (company) — Registrant
- August 5, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-35929 (identifier) — Commission File Number
- 47-0634000 (identifier) — IRS Employer Identification No.
- 1245 Q Street, Lincoln, Nebraska 68508 (address) — Address of principal executive offices
- ( 402 ) 475-2525 (phone_number) — Registrant's telephone number
FAQ
What is the nature of the Material Definitive Agreement filed by National Research Corporation?
The provided excerpt does not specify the details of the Material Definitive Agreement.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on August 5, 2024.
What is National Research Corporation's state of incorporation?
National Research Corporation is incorporated in Delaware.
What is the principal executive office address for National Research Corporation?
The principal executive office is located at 1245 Q Street, Lincoln, Nebraska 68508.
What are the main items covered in this 8-K filing?
This 8-K filing covers Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, and Financial Statements and Exhibits.
Filing Stats: 982 words · 4 min read · ~3 pages · Grade level 13.4 · Accepted 2024-08-06 17:07:53
Key Financial Figures
- $25 million — xed charge coverage ratio covenant from $25 million to $27.5 million. The Third Amendment a
- $27.5 million — rage ratio covenant from $25 million to $27.5 million. The Third Amendment also made certain
Filing Documents
- nrc20240806_8k.htm (8-K) — 34KB
- ex_709154.htm (EX-99.1) — 157KB
- nrclogo1.jpg (GRAPHIC) — 6KB
- 0001437749-24-024947.txt ( ) — 341KB
- nrc-20240805.xsd (EX-101.SCH) — 3KB
- nrc-20240805_def.xml (EX-101.DEF) — 11KB
- nrc-20240805_lab.xml (EX-101.LAB) — 15KB
- nrc-20240805_pre.xml (EX-101.PRE) — 11KB
- nrc20240806_8k_htm.xml (XML) — 3KB
01
Item 1.01 Entry into a Material Definitive Agreement. On August 5, 2024, National Research Corporation, a Delaware corporation (the "Company"), entered into a Third Amendment to Amended and Restated Credit Agreement (the "Third Amendment") with First National Bank of Omaha, a national banking association ("FNB"), that amends the terms of that certain Amended and Restated Credit Agreement, dated May 28, 2020, as amended by that certain First Amendment thereto dated as of September 30, 2022, and that certain Second Amendment thereto dated as of June 16, 2023, by and among the Company and FNB (the "Credit Agreement"). Among other changes, the Third Amendment: (i) extended the maturity date of the revolving loan from May 28, 2025 to May 28, 2027, (ii) extended the commitment date until which FNB will make loans available under the delayed draw-down term facility (the "Delayed Draw Term Loan") from May 28, 2025 to May 28, 2026, (iii) made the outstanding balances on the term loan (the "Term Loan") and both current and any future Delayed Draw Term Loans payable in equal monthly installments amortized over ten-year periods, (iv) changed the applicable interest rate for the Term Loan from a fixed rate of 5% per annum to a rate per annum equal to the secured overnight financing rate or "SOFR," plus 2.35%, (v) extended the use of the Delayed Draw Term Loan to include dividends, stock repurchases, acquisitions, and capital expenditures, and (vi) increased the building renovations excluded from the fixed charge coverage ratio covenant from $25 million to $27.5 million. The Third Amendment also made certain other updates to the definitions, terms, principal amounts outstanding, and conditions of the Credit Agreement to reflect the above-described changes. The foregoing summary of the terms and conditions of the Third Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Third Amendment, a copy of which will be filed
02
Item 2.02 Results of Operations and Financial Condition. On August 6, 2024, the Company issued a press release announcing its financial and operating results for the second quarter ended June 30, 2024. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated by reference herein.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. EXHIBIT NUMBER EXHIBIT DESCRIPTION 99.1 National Research Corporation press release announcing its financial and operating results for the second quarter ended June 30, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). The information contained in Items 2.02 and 9.01 of this report and the exhibits hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The information in Items 2.02 and 9.01 of this report and the exhibits hereto may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act and such statements are subject to the safe harbor created by those sections and the Private Securities Litigation Reform Act of 1995, as amended. Such statements are made based on the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Actual results or events may differ from those anticipated by forward-looking statements. Please refer to the paragraph at the end of the attached press release and various disclosures by the Company in its press releases, stockholder reports, and filings with the Securities and Exchange Commission for information concerning risks, uncertainties, and other factors that may affect future results. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NATIONAL RESEARCH CORPORATION (Registrant) Date: August 6, 2024 By: /s/ Linda Stacy Linda Stacy Secretary, Principal Financial Offi